Kronos Bio Inc (KRON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -112,673 | -87,353 | -55,979 | -26,238 | -133,204 |
| Depreciation Amortization | -3,204 | -2,445 | -1,587 | -684 | 1,733 |
| Accounts payable and accrued liabilities | -4,148 | -945 | -2,550 | 1,005 | 4,025 |
| Other Working Capital | 5,876 | 11,170 | 8,572 | 13,571 | 6,178 |
| Other Operating Activity | 35,567 | 26,015 | 20,572 | 6,399 | 30,342 |
| Operating Cash Flow | $-78,582 | $-53,558 | $-30,972 | $-5,947 | $-90,926 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -679 | -648 | -434 | -126 | -577 |
| Purchase Of Investment | -212,957 | -170,816 | -140,320 | -102,595 | -367,124 |
| Sale Of Investment | 280,004 | 206,272 | 139,773 | 96,366 | 335,479 |
| Investing Cash Flow | $66,368 | $34,808 | $-981 | $-6,355 | $-32,222 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 567 | 376 | 376 | N/A | 851 |
| Financing Cash Flow | $567 | $376 | $376 | $N/A | $851 |
| Beginning Cash Position | 77,999 | 77,999 | 77,999 | 77,999 | 200,296 |
| End Cash Position | 66,352 | 59,625 | 46,422 | 65,697 | 77,999 |
| Net Cash Flow | $-11,647 | $-18,374 | $-31,577 | $-12,302 | $-122,297 |
| Free Cash Flow | |||||
| Operating Cash Flow | -78,582 | -53,558 | -30,972 | -5,947 | -90,926 |
| Capital Expenditure | -679 | -648 | -434 | -126 | -577 |
| Free Cash Flow | -79,261 | -54,206 | -31,406 | -6,073 | -91,503 |